Chen J - Search Results

1

[Intrahepatic sarcomatoid cholangiocarcinoma with osteoclast-like giant cells: report of a case].

Fan XS, Chen J, Wu HY, Qiu YD, Zhang WW, Kong WT. Fan XS, et al. Among authors: chen j. Zhonghua Bing Li Xue Za Zhi. 2010 Sep;39(9):640-1. Zhonghua Bing Li Xue Za Zhi. 2010. PMID: 21092600 Chinese. No abstract available.

2

Low-level clonal FGFR2 amplification defines a unique molecular subtype of intrahepatic cholangiocarcinoma in a Chinese population.

Pu XH, Ye Q, Yang J, Wu HY, Ding XW, Shi J, Mao L, Fan XS, Chen J, Qiu YD, Huang Q. Pu XH, et al. Among authors: chen j. Hum Pathol. 2018 Jun;76:100-109. doi: 10.1016/j.humpath.2017.12.028. Epub 2018 Mar 4. Hum Pathol. 2018. PMID: 29514108

3

Survival prediction on intrahepatic cholangiocarcinoma with histomorphological analysis on the whole slide images.

Xie J, Pu X, He J, Qiu Y, Lu C, Gao W, Wang X, Lu H, Shi J, Xu Y, Madabhushi A, Fan X, Chen J, Xu J. Xie J, et al. Among authors: chen j. Comput Biol Med. 2022 Jul;146:105520. doi: 10.1016/j.compbiomed.2022.105520. Epub 2022 Apr 27. Comput Biol Med. 2022. PMID: 35537220

4

Clinicopathological, radiologic, and molecular study of 23 combined hepatocellular-cholangiocarcinomas with stem cell features, cholangiolocellular type.

Chen J, He J, Deng M, Wu HY, Shi J, Mao L, Sun Q, Tang M, Fan XS, Qiu YD, Huang Q. Chen J, et al. Hum Pathol. 2017 Jun;64:118-127. doi: 10.1016/j.humpath.2017.01.016. Epub 2017 Apr 18. Hum Pathol. 2017. PMID: 28431889

5

Predicting IDH mutation status of intrahepatic cholangiocarcinomas based on contrast-enhanced CT features.

Zhu Y, Chen J, Kong W, Mao L, Kong W, Zhou Q, Zhou Z, Zhu B, Wang Z, He J, Qiu Y. Zhu Y, et al. Among authors: chen j. Eur Radiol. 2018 Jan;28(1):159-169. doi: 10.1007/s00330-017-4957-y. Epub 2017 Jul 27. Eur Radiol. 2018. PMID: 28752218

6

Target molecular treatment markers in Intrahepatic Cholangiocarcinoma based on Chinese population.

Pu X, Zhu L, Li F, Zheng J, Wu H, Fu Y, Chen J, Qi L. Pu X, et al. Among authors: chen j. Pathol Res Pract. 2020 Sep;216(9):153116. doi: 10.1016/j.prp.2020.153116. Epub 2020 Jul 11. Pathol Res Pract. 2020. PMID: 32825971

7

Quantitative Proteomics Reveals Down-Regulated Glycolysis/Gluconeogenesis in the Large-Duct Type Intrahepatic Cholangiocarcinoma.

Guo Y, Li Q, Ren W, Wu H, Wang C, Li X, Xue B, Qiu Y, Zhang J, Chen J, Fang L. Guo Y, et al. Among authors: chen j. J Proteome Res. 2022 Oct 7;21(10):2504-2514. doi: 10.1021/acs.jproteome.2c00472. Epub 2022 Sep 6. J Proteome Res. 2022. PMID: 36066509

8

C-MET in intrahepatic cholangiocarcinoma: High-Frequency amplification predicts protein expression and a unique molecular subtype.

Pu XH, Yue S, Wu HY, Yang J, Fan XS, Fu Y, Ye Q, Chen J. Pu XH, et al. Among authors: chen j. Pathol Res Pract. 2020 Apr;216(4):152857. doi: 10.1016/j.prp.2020.152857. Epub 2020 Feb 11. Pathol Res Pract. 2020. PMID: 32089411

9

Typing FGFR2 translocation determines the response to targeted therapy of intrahepatic cholangiocarcinomas.

Pu X, Ye Q, Cai J, Yang X, Fu Y, Fan X, Wu H, Chen J, Qiu Y, Yue S. Pu X, et al. Among authors: chen j. Cell Death Dis. 2021 Mar 11;12(3):256. doi: 10.1038/s41419-021-03548-4. Cell Death Dis. 2021. PMID: 33692336 Free PMC article.

10

LRRK2 Is Associated with Recurrence-Free Survival in Intrahepatic Cholangiocarcinoma and Downregulation of LRRK2 Suppresses Tumor Progress In Vitro.

Gu S, Chen J, Zhou Q, Yan M, He J, Han X, Qiu Y. Gu S, et al. Among authors: chen j. Dig Dis Sci. 2020 Feb;65(2):500-508. doi: 10.1007/s10620-019-05806-0. Epub 2019 Sep 5. Dig Dis Sci. 2020. PMID: 31489563

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

139,340 results

Search Page

Filters